Affiliated Faculty
F. Reed Johnson, PhD
Contact
Degree
PhD, State University of New York at Stony Brook
Johnson FR, Gonzalez JM, Yang J-C. What Is the Consensus Value of Patients' Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease. Value Health. 2026 Jun;29(6):1086–94.
Sutphin J, Wallace MJ, Reed SD, Duke PrefER and FDA Patient Preference Methods Working Group. Means Can Be Deceiving: Comparing and Contrasting Risk Tolerance Estimates From a Discrete-Choice Experiment and a Threshold Technique Exercise. Value Health. 2026 Feb;29(2):295–302.
Yang J-C, Janssen EM, Wallace MJ, Sheahan A, Lynch J, Bewtra M, et al. Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease. Am J Gastroenterol. 2025 Dec 1;120(12):2848–56.